About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Treatment of Incurable Blood Cancer on the Anvil

by Kathy Jones on July 18, 2010 at 2:14 PM
Font : A-A+

 Treatment of Incurable Blood Cancer on the Anvil

A conceptually new model for the development and progression of multiple myeloma has been presented by researchers from Uppsala University. Myeloma is one of the most common blood cancers, and at present considered to be incurable.

Using large cohorts of myeloma patients, the researchers have identified a profile of genes that are silenced by epigenetic mechanisms in the malignant plasma cell.

Advertisement

"This silencing may lead to the uncontrolled growth of the malignant cells," said Helena Jernberg Wiklund, one of the investigators in the study.

The silenced gene profile was compared and contrasted to normal plasma cells, which are highly specialised and for which growth and lifetime is tightly controlled.
Advertisement

The silenced genes have a common denominator in being targets and controlled by the Polycomb repressor complex (PcG).

This complex has previously been implicated in self-renewal and division of normal embryonic stem cells.

In the study, the researchers found that inhibitors of PcG also could decrease the growth of tumour cells in an animal model of myeloma.

"A new strategy for treating multiple myeloma could be to develop drugs that are targeted to the PcG complex, leading to reactivation of the silenced gene profile", said Helena Jernberg Wiklund.

The study is published in the latest edition of the on-line journal PLoS ONE.

Source: ANI
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Cancer News

 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
Hope for Lethal Brain Tumors: Targeted Therapy Delays Glioma Progression
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Treatment of Incurable Blood Cancer on the Anvil Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests